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IDAHO FALLS , IDAHO , WEDNESDAY , AUGUST 22 , 2012 
1 : 32 P . M. 
REFEREE DONOHUE : Good afternoon . 
This is the time and place according to the 
Notice for the hearing in the matter o f Kurt Aikele 
versus City of Blackfoot and the Idaho State 
Insurance Fund . 
Claimant is present represented by Mr . Adams 
and Mr. Curtis . I presume this is your wife? 
THE CLAIMANT : No . 
REFEREE DONOHUE : No. Okay . See , I missed . 
MS . WILDING : No . I ' m 
REF EREE DONOHUE : Wou ld you introduce yourself , 
please . 
MS . WILDING: I ' m Diane Wilding . I'm a 
paralegal to Paul and Andy . 
REFEREE DONOHUE: Oh , okay . 
MS. WILDING : Okay? 
REFEREE DONOHUE : All right . Thanks . 
And the Defendants are represented by 
Mr . Fuller . 
This is Docket No . 08-040432 . The Notice of 
Hearing is inaccurate. So disregard that . 
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It ' s a bifurcated hearing and the - - looks like 
really two issues , whether Norman Zuckerman , M. D. , 
has become a treating physician and which statute of 
limitation applies . Does that fairly set forth what 
we need to talk about? 
MR . ADAMS : Think so . 
MR . FULLER : Yes. 
REFEREE DONOHUE : Okay . Very good . I ' ve 
rece i ved a set of joint exhibits , looks like eight 
exhibits tota l ling 29 pages . Does either side have 
any objection to the admission of any of these 
documen t s? 
MR . ADAMS : We do not . 
MR . FULLER : The Defendan t s , no. 
MR . ADAMS : Claimant , no . 
REFEREE DONOHUE : 
exhibits are adm i tted . 
Very we l l then . The joint 
Okay . Mr . Adams , then opening statement if you 
please . 
MR . ADAMS : Okay . Essentially what we ' re doing 
here today is Kurt Aikele was sent to 
Dr . Norman Zuckerman for an independent medical 
examination . We believe and we ' re -- hopefully can 
show through the evidence that Dr. Zuckerman , upon 
giving recommendations for treatment , gave medical 
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eventually gave a medical benefit to the Cla imant 
thereby extending the statute of limitations from one 
year to five years . 
We have -- the records are clear that he gave 
recommendations that Mr . Aikele was not receiving in 
time from Dr . Dickson , and the record ' s clear that 
that visit was paid for by the , by the Surety . 
Therefore , we believe compensation was paid ; and as 
compensation was paid , that the statute ' s extended . 
And , therefore , we should be able to move on from 
this hearing and eventually address the other issues . 
REFEREE DONOHUE : Thank you. 
Mr . Fuller. 
MR . FULLER: Thank you. 
We just have a -- I just have a couple of 
things I wanted to mention . 
This claim , I believe , began with a notice of 
manifestation of disease , occupational disease ; and I 
believe that was dated 12 - 16 - 08. A complaint was 
filed by other counsel ; and a considerable amount of , 
of discovery was done or at least written discovery 
with him . 
And ultimate -- and a -- two IMEs were actually 
done , Dr . Pfoertner ' s and Dr . Zuckerman. 
Dr . Zuckerman ' s IME , the one that counsel has 
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mentioned , will be at issue here today . 
The original complaint was dismissed , and an 
order dismissing complaint dated June 23 , 2010 , was 
entered by the Commission . And then , of course , this 
subsequent complaint has been f i led trying to revive 
the issue again . 
We have - - I would indicate that the Fund has 
paid nothing with regards to this claim other than 
for the two IME physicians to perform their 
evaluations ; and also I believe they paid for the 
mileage of Mr . Aikele to go to the IMEs . I know of 
no other payments that have been made , and I th i n k 
counsel is -- wo u ld probably agree with that . 
MR . ADAMS : Yes . 
MR . FULLER : So I think we can stipulate to 
that particu l ar fact so that we don ' t have to put 
anything on with regards to that . 
Today we -- oh . In the , in the exhibits there 
are some references or some materia l s with regards to 
the First Report of Injury . Counsel , other counsel 
had raised a couple of issues regarding whether or 
not the form or the notice was proper or had been 
filed properly . 
But that issue I was told today would not be 
raised , that tha t is being withdrawn . In fact , it 
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was never raised with , with the Commission yet. We 
were talking about it just this last week , I believe . 
That will not be raised today ; but I wanted the , I 
wanted the Referee to know why some of those 
documents were in the exhibit list . 
will not be refer enced a great deal . 
They probably 
It is our contention that Dr . Zuckerman was not 
a treating physician for purposes of extending the 
statute , that he merely provided services as an 
independent medical evaluator , a consultant , if you 
will, and not as a treating physician . 
Thank you. 
REFEREE DONOHUE : Call your first witness . 
MR. ADAMS : We ca ll Kurt Aikele. 
REFEREE DONOHUE : Mr. Aikele , the court 
reporter will swear you in . 
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KURTH . · AIKELE , 
the Claimant herein , called as a witness on his own 
behalf , being first duly sworn , was examined and 
testified as follows : 
DIRECT EXAMINATION 
BY MR. ADAMS : 
Q. Okay . I'm go ing to just start off with 




So could you state your name , your full 











Kurt H. Aikele . 
Okay . And co u ld -- and where were you 
Pocatell o . 
And where did you g r ow up? 
Arco . 
And when was your b i rthdate? 
November 8th , ' 54. 
Have you lived in Southeast Idaho all 
A . Except for about two years in Oregon 
actually living -- served an L.D . S . mission in Iowa 
for two years , but I d o n ' t think co unts or not. 
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Q. Okay . When you got home from there , 
what, what became your prima r y profession? 
A. Initially agriculture , farming 
operations , crop , row crop , and livestock . 
Q. And then thro u g h out your life , what has 
become your primary or your staple occupation 
throughout your lifetime? 
A . Since -- f o r the last 25 years it's been 
EMS , firefighter , EMS oper a tions , response . 
Q . And what does that job consist of as far 
as duties and whatnot? 
A . Fire is direct response for any type of 
wildland , urban interface , structur e fires. EMS is 
any type of medical emergency . Yeah . 
Q . Ok a y . And how long did you do that j ob 




Full time just this -- 20 years. 
Twenty years? 
Ye s, full time . 
Q. And when did that -- when did you stop 
doing that job? 
A. Last November . 
Q. Last November . Now , we ' re here about 
your worker ' s compensation injury or occupational 
disease . Can you just --
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MR . ADAMS : And with permiss i o n, like to have 
Mr . Aikele give a narrative of his treatment 
beginning from then till now just so we can get that 
out of the way . 
REFEREE DONOHUE : Sure . 
THE WITNESS : Okay . Initially came on just as 
really weird . My legs hurt. My feet and my lower 
legs hurt . Finally went to the doctor mid October , 
and he sent me to the podia t rist who prescribed --
thought it was planta r fasc i tis , and so we got some 
just i n serts in your shoes t o t reat that . 
And i t got worse , hurt worse after two weeks . 
So I went back to my -- Dr . McKinlay , my general 
physic i an ; and he just decid e d just on a guess , just 
as a rule , to do a D- dimer blood clot test . And it 
was over 5 , 000 , which is s i gn i ficant clotti n g in t h e 
system . So he said , " Well , there ' s definitely 
something wrong ." 
So he se n t me for a -- can ' t remember if it was 
chest x - ray or a CT at that point . I think maybe 
just a chest x - ray , which showed some clotting in the 
l u n gs at t h at point ; and so that -- and I think that 
also showed the , the hot spot in the left lymph nodes 
i n my armpit . 
That resulted in the -- Dr . Cardinal doing a 
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biopsy , an x -r ay guided biopsy of that left lymph 
node , which resulted in the o riginal diagnos i s of 
adenocarcinoma primarily in the left lung around the 
heart great vessels . Immediately recommended going 
to Teton Oncology , Dr. Dickson . 
Our first visit with Dr . Dickson , the 
expla nati on of -- or the choice of either going to 
Huntsmans or staying here in Rexburg was kind of 
reviewed the , the idea that if -- they work on a 
regional diagnostic system , database ; and the 
diagnosis tha t you ' d ·get at Huntsmans , basically 
every place in the Northwest , if you get the same 
diagnosis , yo u get the same treatment . 
And so there's -- if -- unless you're going to 
be involved in a clinical trial or some experimental 
site, the same benefit would be received by staying 
here versus traveling t o Utah . 
and continue treatment . 
We chose to stay here 
At that point , somewhere right in there, right 
after the diagnosis , notified work that , that I was 
going to be , I think for at least a month, at first , 
right after the initial diagnosis , which would have 
been I think mid December when we actually got the 
diagnosis -- was off work for I think 30 days , I 
think , for that first month when we initially got the 
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diagnosis and then started initial treatment back to 
the point when we found out what treatment was going 
to be l ik e , physically and mentally, what it was 
going to do to me and , and then was able to return to 
work I think near the end of January I think . 
And so in that time f r ame , the work comp claim 
was initiated if my memory serves me correctly; and 
we were working through that at the same time we were 
doing treatment . 
Continued basically that same treatment 
regimen. 
rad i ation . 
They didn ' t do any surgery . There was no 
Just straight chemo for this type of 
cancer was the only treatment available . 
doing just chemo every three weeks . 
So we were 
At one point they changed to one medication ; 
and they would do the same drug three months --
three - month cycles , treat every three weeks for three 
months . Then they do a set of CTs to determine i f 
the cancer was under control ; if it was moving; if , 
if they ' d reduced the cancer . And at one point 
virtually invisible, had almost gotten rid of it or 
wasn ' t able to be seen . 
And after that had a recurrence , c h anged drugs. 
Every time that there was a change in the cancer on 
the CTs , they changed medications . So we worked 
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through five or six different medications . 
The - - to back up in time , I guess , the 
appointment with the - - the appointment with , through 
the Insurance Fund , with Dr . Zuckerman and , and their 
request for Dr . Pfoertner , according to the 
paperwork , is in January , that same January . 
January 10 , 2010 , I think is what the paperwork 
showed . 
And I just got a letter saying that I was 
supposed to be there and visit with Dr . Zuckerman ; 
and , and we weren ' t sure what that - - I don ' t 
remember ever being told that that was an IME , an 
independent medical exam , just a - - just be there . 
And I kind of assumed that ' s what it was . 
object . 
going 
MR . FULLER : I , I guess I ' m just going to 
That ' s going beyond narrative . This is 
THE WITNESS : Okay . 
MR . FULLER : - - to the heart of the matter that 
should be responding to questions and answers rather 
than simply a narrative exposition . 
THE WITNESS : That ' s true . 
REFEREE DONOHUE : Fair enough. 
THE WITNESS : You ' re right . 
REFEREE DONOHUE: Fair enough . 
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THE WITNESS : Yep. 
REFEREE DONOHUE: Sustained . 
THE WITNESS: Okay. So we just went to 
Dr . Zuckerman , visited with him , and came home , went 
on with the treatment recommended by Dr . Dickson . 
And , and I think last November had a situation 
where the - - my condition was getting worse and 
worse . On oxygen at home , had been on just at night ; 
and then it progressed to the point that I needed to 
be on it all day. 
Last thing they tried through Teton Oncology 
was , well , let's , let ' s just try -- this is getting 
worse and worse . It didn ' t -- they could tell there 
was some progression with the cancer , but not related 
enough to the , to the CTs to think that it was an 
absolute , you know , ends up progression . So they 
just tried a , a round of antibiotics and that 
turns out that it was just a pneumonia . That took 
care of the , the symptoms for the moment . 
But at that point they'd asked me to I was 
too sick to go to work. So I'd been off work ; and 
they just said , " Well , we ' re pretty much done. We ' re 
not going to let you come back ." And so forced , 
basically , forced retirement last November . 
And so since then , they -- Teton Oncology, the 
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original cancer treatment facility , said that they 
didn ' t have anything else . They were at the end of 
the i r algorithm for treatment . 
And so we spent a couple of months at home 
fretting over whether to j u s t l e t i t take i t s co u rse 
or what we should be doing ; and , and my wife finally 
c a lled the Cancer Treatment Cen t ers of Ame ri ca . And , 
and they flew us to Chicago to do an evaluation back 
there and felt like that the cancer was still there . 
I t hadn ' t changed a lot in a year , but they wanted to 
they felt the r e , there , there was other avenues of 
treat ment available . 
And so we watched the cancer for t h ree month s; 
and t hen t hey fe l t like , wit h the next set of CTs , 
that there was enough of a change that they resumed 
chemo . And , and so that ' s where we ' re at n ow. 
Transferred to Phoenix becau s e of a change in 
insurance that made it pos s ible to go to Phoenix ; 
b u t , otherwise , we ' re just resuming treatment wit h 
chemo . 
About it . 
Q. BY MR . ADAMS : Well , thank you for going 
through all of that . 
question s 
A . Okay . 
I ' m go i ng to just ask you a few 
13 




























Q. -- about some of those things . 
First question , just so we can get this out , so 
when - - what was your understanding of the diagnosis 
and prognosis that Dr . McKinlay gave you? 
A . Dr . McKinlay -- well , through 
Dr . Cardinal Dr . Cardinal made the original 
diagnosis in conjunction with Dr. McKinlay . But they 
just said it was lung cancer . They didn ' t --
adenocarcinoma , I don't think they did a , a lot of 
detailed explanations to that extent . I don ' t think 
we got the full picture until we went to Dr . Dickson 
wh e n he said , " No , this is " -- he said , "T yp i cally 
p eople with lung cancer , 50 percent of them are dead 






First year . 
Yeah . 
Did you tell your supervisor? 
About the mortalities? 
Did you tell your supervisor that you ' d 





Yes , yes . 
Okay . And who did you inform? 
Kevin Gray . 
And , and do you know if he informed the 
State Insurance Fund about the injury or occupational 
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A . I - - n o t , not for certain . I presume 
that he did because we got the , the correspondence 
that started coming from State Insurance Fund , so . 
Q . The c o rrespondence , did they say if your 
claim had been accepted or denied? 
A. I don ' t remember at what point it was 
denied . I think initially they just - - no , I don ' t , 
I don ' t r emember where , where the denial came into 
place , if that was before Zuckerman or after 
Zuckerman , where that actually came in place . 
Q . And which insurance company was paying 
for your medical bills at th i s time? 
A . That would have been Blue -- I think 
BlueShie l d . 
Q . BlueShield . 
about in the stipulations , 
any of your bills? 
But as we ' ve already talked 
the Surety was not paying 
A . That ' s correct . 
Q . Okay . And Dane Dickson was your treating 
physician ; is that what I heard you say? 
A . Yes , oncology , oncology physician . 




Okay . I ' m g o ing to fast forward now to 
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I ' d like to look at Joint 
Exhibit Page 29 . 
MR. ADAMS : May I approach the bench? 
RE FEREE DONOHUE : Yes . 
Q. BY MR . ADAMS : The first line is what I ' m 
interested in here . It says that the State Insurance 
Fund arranged an independent medical exam with 
Dr. Norman Zuckerman on Tuesday , December 8th , 2009 ; 
is that correct? 
Yes . A. 
Q . What is your - - first off , how ' d you find 
out about this , this independent medical exam? 
A. To , to my recollection - - I didn ' t go 
back and look to see actually what correspondence I 
received , but all I remembered receiving was just a 
notice f r om the lawyer to be in Boise to visit with 
Dr . Zuckerman at the Mountain States Tumor Institute 
on the time and place or the date and time . 
Q . And what was your understanding of an 
independent medical exam if that ' s what you ' re - -
A. I didn ' t , I didn ' t remember seeing that 
it was that wordage . I just remember having -- being 
told to b e there for ' cause that was the State 
16 





























Insurance Fund ' s follow , follow - up exam if that ' s the 
right word or if that ' s an appropriate word . 
Q. Okay . Let me -- if I can get the 








Did you attend this appointment? 
Yes . 
Do you remember Dr . Zuckerman? 
Yes . 
Can - -
A . Probably couldn ' t point him out ; but , but 
I was there . 
Q . Did you sign a disclosure or any other 
type of document at Dr. Zuckerman ' s office which 
bas i cally said that no patient - client or 
patient-doctor relationship was being 
A . Not to --
- - f ormed? 





Did you sign anything at his office? 
Traditional patient documents . 
privacy documentation, or HIPAA disc l osure 
documentation , insurance bil l ing information . 
I mean 
I 
don ' t remember if th ey took a copy of my insurance 
card or n ot . 
17 


























Q. When they took your insurance 
information , did they ask for BlueCross ; or did they 
ask for the State Fund? 
A. That ' s -- they didn ' t ask for anything 
for -- from State Insurance Fund , but I think I gave 
them just the traditional information like you were 




When you walk through the door , they 
just , fi ll out this paperwork and give us a copy of 
your insurance card . But I , but I don ' t specifically 
remember that . That ' s , that ' s my , that 's my feel i ng 
of what happened . 
Q . Was there a different type of 
relationship with him than with the other doctors 
that you ' ve seen over the last f ou r years? 
A . For that exam I didn ' t think so . I mean 
it was he was very cordial . He was very 
informative . He was -- he , he gave us some ideas 
about where we were -- what was going to happen , 
where we were going ; went through th e description 
again , the type of cancer that it was , and , and where 
we were going to be headed with it , and what it 
what the -- the realistic expectations that we should 
be looking at . 
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Q. Okay. Did you -- about how long was the 
visit? 
A. I think it was half hour , 45 minutes . 
Q . Did -- on December 8th , 2009 , did he tell 
you whether or not the cancer was related to your 
occupation as a firefighter? 
A. He kind of gave us the opinion that he 
didn ' t think it was . 
Q. Okay . 
A. 
the other . 
But he didn 't, he didn ' t say one way or 
Q. So --
A . Specifically . He didn 't say , no , this 
isn 't. He just says , " My research , I ' ve just done a 
little bit of research , just -- and it doesn ' t look 
like it , it is." 
MR. ADAMS : Okay . Can I approach the bench? 
Q . BY MR . ADAMS : If you look at what ' s 
marked as Exhibit 3 , Page 3 , it appears that these , 
these are some notes ; and they are carbon copied to 
Dr. Dane Dickson and to Teresa Raymond at the State 
Insurance Fund. But can you take a look at that and 
see if that sounds about accurate to -- as your visit 
that day, as 
A . (Reading.) Yeah , uh-huh . (Affirmative . ) 
19 




























So - -Q. 
A . I remember he , he mentioned these 
articles to me ; and I was a little upset -- maybe 
that ' s not quite the right word . I was a little 
discouraged that all the articles , t h e datas - - the 
data that he mentioned having looked at was all old 
stuff . Old , old research was , was what I came away 
from that with , that he had -- the thing that he ' d 
mentioned was a little older than the stuff that I ' d 
looked at. 
Q. Okay . But essentially he told you " I 




Okay . Did he give you any 
recommendations that day for treatment? 
Yes . A . 
Q. What was your understanding of the 
recommendations that he gave you? 
A . Just kind of -- I , I guess kind of along 
the same line that , that we 'd already talked about , 
that it was just -- he kind of reviewed with us the 
whole diagnosis and what was happening . He had a lot 
of questions about what had been done , what we ' d been 
doing , and where we were at in the treatment , and 
whether or not other things had been tried . The -- I 
20 





























think the one that you're referring to is the EGFR? 
Q. Yeah. Let ' s turn to that page. 
MR. ADAMS : 
that page. 




BY MR . ADAMS: On , on Page 2 , His tory and 
he has a -- about halfway down there ' s a 
recommendations . First, I want to talk 
about that first recommendation right now, the one 
talking about lifelong anticoagulation . 
A . Okay. 
Q. Before you were there that day, before 
you saw him well , first off , did he recommend that 
that day? Did he recommend --
A . Oh , yeah . Yeah. 
Q. Okay . 
A. He said, " You need to be absolutely - -
you ' re going to be on something for the rest of your 
life . Whatever , whatever your life is , you 'r e going 
to be on an anticoagulant for the rest of it ." 
Q. And did Dr . Dickson , from your 









































Are you still on an anticoagulation? 
Yes . 
Okay . While it ' s not " herapin ", what --











Sor ry abo ut that . 
This one 's called Pradaxa. 
Is it 
It ' s a , kind 
of a , a newer medication t ha t , that isn 't 
specifi cally authorized in the United States for , for 
just an anticoagulant like Coumadin is. 
treating blood clo ts in hea rt patients . 






But nonethe less you ' re still on --
-- an anticoagulation? 





Yes , uh-huh . 
Oka y . 
(Affirmative . ) Yeah . 
We , we had started that with Dr . McKinlay 
originally when we found out about the blood clots , 
the c l ots in the legs . 
Q . When you heard that he agreed that you 
22 




























sho u ld be on anti c oagulation medic i ne , how did that 
make you feel at that time about your current 
treatment that you were getting from Dr . Dickson? 
A . Well , I knew we were on the -- he was a 
Zuckerman ' s a really nice guy , just seemed l i ke a 
really good doctor , very concerned . He - - we had 
discussed that and discussed the difficulties and the 
challenges that we ' d had with that already in the 
short time frame and agreed that we needed to be on 
something . 
We ' d had trouble with Coumadin . Coumadin was 
the -- is the , the primary anticoagulation that 
everybody ' s on . But , but I' d been on it for months , 
and we still had trouble with the clots . And come to 
find out , my , my Coumadin , at one point , level was 
just to the point that you should be in the hospital 
' ca u se if you just bump yourself , you ' re going to 
bleed internally r and it won ' t stop . 
Q . Okay . 
A . And it didn ' t matter how mu ch Coumadin I 
took , I never had a bleeding problem . 
Q. Was Dr . Zuckerman the first one to 

































A . No , no . He , he just talked about the 
idea that we were going to have to be on something ; 
and because of the problems I had with the Coumadin , 
I was going to have to be on a heparin-based ' cause 
that was the only thing available at that point . 
Pradaxa wasn ' t even on the - - wasn ' t even -- I'm sure 
it was in experimental stage at that point , but it 
wasn ' t approved anywhere for use . 
Q. Okay . Let ' s move on to the next - -
A . Okay . 
Q. -- recommenda t ion there . The - - he a l so 
recommends an EGFR . 
A . Okay. 
Q. What is your understanding of an EGFR? 
A . EGFR is a genetic marker that if you have 
that genetic marker , a , a drug called Tarceva will 
kill the cancer just about 90 , 98 percent . 
works every time . 
It , it 
And so the idea tha t we hadn ' t had a EGFR yet 
was a l i ttle surprising to him ; and he said , " You 
need that EGFR " and sent that recommendation back to 
Dr . Dickson . And , and when I got back to Dr . Dickson 
and we reviewed that , he was a little surprised and 
realized that they ' d forgot to do -- they hadn ' t done 
it , and had that done immediately . 
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MR . ADAMS : Okay . Can I approach? 
REFEREE DONOHUE : Sure . 
Q. BY MR. ADAMS : All right . So if we look 
at Page well , it's not going to be the same page 
in that one . If we look a t Page -- on Page 27 , 
halfway down , there ' s a -- ca n you tell me the date 
of t his record? The date , the date ' s at the top of 
the page ; but then we ' re going to focus on what's in 
the middle of the record. 
A. The run date ' s middle of December , ' 09. 
12-2 3 -09 is the run date for the , for the lab . This 




What we ' re looking at is EGFR . 
Okay . 
Do you know if this is what EGFR stands 
for , halfway down -- I ' m going to mispronounce 
that - - glomerular filtration rate? 
A. Filtration rate? That should be kidney 
function is what , what that -- I think that is. 
Q. 
A. 
Oh , the -- this right here? 
Yeah , glomerular filtration rate , how 
well your kidneys are functioning is what that's a 
measure of . 
Q . Okay . Is there anything on either one of 
these two records that indicate that the EGFR was 
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done or on Records 27 and 28 , that the EGFR was 








The -- okay . All right . Well , but 
nonetheless , the EGFR was done after he recommended 
that it be done? 
A. 
Q. 
Yes , uh - huh . (Affirmative . ) Yep. 
And what was the results of the EGFR if 
you can remember? 
Negative . 
It was negative? 
A. 
Q. 
A . Yeah . There was no -- so that meant that 
the -- if and this is just you should have 
called my wife to the witness stand . 
this stuff like a book . 
She remembers 
But I think that they had me on the drug of 
Tarceva at that point , and the indication for going 
on Tarceva is a positive EGFR . And so without 
having -- with a negati v e EGFR , there ' s - - the 
Tarceva is basically a placebo . It doesn ' t do mu ch 
good . So I think that at that point we also changed 
drugs as a result of -- go ahead . 
Q. Oh , I was going to say , on that note , 
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turn to Dr . Zuckerman ' s record -- recommendations . 
Uh-huh . (Affirmative.) A. 
Q. Back to Dr . Zuckerman ' s recommendations, 
on Page , on Page 5 , he talks about the EGFR. 
Uh - huh. (Affirmative .) A . 
Q . Can you tell me if that course of 
treatment was followed by Dr . Dickson? Bottom 




He wanted to - - Tarceva if I , if I 
He says if, if , if his EGFR 
mutation is positive, he should be considered for 
erlotinib maintenance. And I don ' t remember what 
Pemetrexed is, Pemetrexed , what the common name for 
that is . I could look it up real quick . 
Q. Okay. But after the EGFR was done , your 




Okay. If we go back --







BY MR . ADAMS : He also recommend a PET? 
PET scan . 
A PET scan? 
Uh - huh . (Affirmative.) 
Did you undergo a PET scan? 
No, no . We, we had been doing contrast 
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CTs up to that point , and my understanding of the 
difference between a PET scan and a CT scan is a tiny 
bit better resolution on the PET scan versus a CT 
scan. So you can see things a little more clearly on 
the PET scan . 
But I think at this time the PET scan was about 
twice as much money as the CT scan was I think ; and 
Dr . Dickson felt like he was getting the type of 
images , the type of stuff that he needed to see , 
progression or regression of the cancer , through the 
CT scans . And he didn ' t need to do a PET scan . 
Q. Didn ' t need to do one. These 
recommendations , to the best of your knowledge , 
were sent to Dr. Dickson? 
A. Yes . 
they 
Q. With your conversations with Dr . Dickson , 
what ' s your understanding of what he thought of these 
recommendations? 
A. He was , he was appreciative of the idea 
of the recommendation on the EGFR . I ' m not sure why 
he hadn ' t thought of that ; but , but he definitely 
followed through with that EGFR recommendation to 
rebiopsy the tumor for that genetic marker . 
Q . Okay . Is it - - and you said you had two 
more EGFRs done after that? 
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A . Over the time . They ' ve just restaged 
the -- well , I don't know if the restaging is the 
right word . They ' ve rechecked that just to be sure 
that that , that was correct because the, as I said , 
the idea of the Tarceva is so successful , so 
beneficial that they wanted to be sure that that 
that there wasn ' t an error there , and they wanted to 
make sure that it that that wasn ' t positive. 
Q. Okay . Did you receive your denial 






I don ' t remember. 
Can you remember? 
I don ' t . 
If we look at the letter that 
Dr . Zuckerman wrote to Teresa Raymond -- I believe it 
starts on Page 4 , Page 4 or Page 5. 
that she 





Yeah, uh-huh . (Affirmative . ) 
Yeah . What ' s the date on that? 
That is January 21st of '1 0 , 2010. 
January 21st of 2010 . Was it before or 
after that that you received notice that your claim 
had been denied? 
A . I don ' t , I don ' t know when the date --
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when we actually received the notification that it 




I presume - - that seems pretty early to 
me ; but that , that ' s probably about the right time. 
Probably around that same time frame . 
Q. Okay . Looking at the date of that 
letter , was your EGFR done before or after that 




After I ' m sure . A. 
Q. 
A. 
Q. Al l right . Now , if we look at Page --
let 's look at the Exhibit -- I believe it ' s marked 
Page 21. Let ' s look at Page 21 for a second . These 
are the -- this is a letter wr itten by Teresa Raymond 
to Dr . Zuckerman . Is that the right -- have I got 
the right one? Yeah . 
This is the end of the letter . 
she wanted Dr . Zuckerman to look at : 
This is what 
What is your 
current diagnosis , prognosis ; and on a more probable 
than not work related -- do you see those two 
paragraphs right there? 
A . 
Q. 
Yes , uh-huh . (Affirmative.) 
Do you believe that Dr . Zuckerman saw you 
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for those two points , that he expressed his opinions 




Okay . Now , on that note , did 
Dr . Zuckerman -- you know , we know he gave you those 
recommendations . Beyond that , do you feel that the 
recommendations that he gave you that were not 
encompassed in those two points , the additional 
recommendations do you believe that those 
recommendations he gave you have been beneficial to 
you as a medical benefit or a medical service in your 
overall treatment of - -
A . Oh , yeah . 
MR . FULLER : Objection , calls for a legal 
conclusion . 
THE WITNESS : Okay . 
REFEREE DONOHUE : Well , we ' re not guessing that 
he ' s an attorney . So I ' ll overrule . 
THE WITNESS : I thought they were . 
Q. BY MR . ADAMS : Just to your 
understanding . 
A . Just , just , just the idea of another set 
of eyes looking at the same problem ; and , and he was 
very informative and helpful . I t , it didn ' t feel - -
I don ' t know if that ' s appropriate or not - - didn ' t 
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feel like just an exam to me . It felt like he was 
just - - it was a consultation is what it felt like . 
Q. And on that note , let ' s - - if you turn 
the page , you have a copy of Norman Zuckerman ' s bill . 
A . Uh - huh . (Af firmative . ) 
Q. What , what does it , what does it say 
there as far as what he billed them -- the 
industria l -- the State Insurance Fund that day for? 
A . Hematol o gy/oncology consultation --
consulting fee . 
Q . And when you read that as someone - -
again , your personal opinion , your understanding of 
so meone who ' s been in the med i cal pro f es s ion for 20 
years as an EMS , how do you interrupt that to you? 
MR . FULLER : I ' ve got to object to that . 
REFEREE DONOHUE : Yes , I ' 1 1 sustain that one . 
MR . ADAMS : Okay . Al l rig h t. All right . 
That ' s fine . That ' s fine. 
Q. BY MR . ADAMS : But , anywa y , do you - -
what is yo ur understanding of -- okay . Again , just 
if you ' ll read that , that does not say "i ndependent 
medical exam " ? 
A. No . 
MR . FULLER : Document speaks for itself . I ' m 
going t o object to this line of questioning . 
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REFEREE DONOHUE : Sustained . 
MR . ADAMS : Okay. That ' s fine . 
I think at that point I do not have any more 
questions at this time . 
REFEREE DONOHUE : Okay . Cross . 
MR. FULLER: Thank you . 
CROSS EXAMINATION 
BY MR . FULLER : 
Q. Mr . Aikele , my name 's Steve Fuller . I 
represent the Employer in this matter and the Idaho 
State Insurance Fund . 




Given what I ' d read about your condition , 
I understand that that is perhaps unexpected that you 







So we hope the best for you in the 
Thank you . 
I 'm going to focus my questions on the 
examination that was performed , the evaluation that 
was performed by Dr . Norman Zuckerman --
A . Okay. 
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Q. -- on behalf of the State Insurance Fund . 
If you could look at - - I think you still have 
those exhibits in front of you . Could you look at 
Page 29? It ' s the very last exhibit -- no . Excuse 
me . Yeah , that ' s correct . It ' s the letter dated 
November 19 , 2009 . Do you have that in front of you? 
Uh-huh. (Affirmative . ) Yes . A. 
Q. Now , that letter is addressed to you in 






Was he your attorney at that time? 
He was at that time , yes . 
Now , in your previous testimony you 
indicated that I thought you indicated that you 
had received a letter from him. 
copy of this letter? 
Did he send you a 
A. I don ' t specifically recall that . 
don ' t remember seeing this , but that doesn't 
actually 
I 






Yes , that ' s correct. 
In any event , you did receive a letter? 
Notifi cat i on , yes . Yep . 
And what was the g ist of that 
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notification as you recall it? 
A. That I was to be at this time and date 
December 8th at 9 : 30 , I was to in , in Boise at the 
Mountain States Tumor Institute . 
Q. Now, did you understand you had a choice 






I guess not . 
You understood that you needed to be 
That's correct , yes . 
Okay . Well , there's a difference I 
think , Mr. Aikele , between you choosing a doctor that 
you want to go see and be ing sent to a , a doctor such 
as Dr . Zuckerman for an independent medical 
evaluation. Do you understand that difference? 
A. Uh - huh. (Affirmative . ) Yeah , uh-huh. 
Q. Okay . How do you -- and tell me what you 
understand with regards to that difference . What is 
the difference in your mind between being required to 
go see Dr . Zuckerman and you choosing your own 
physician? 
A . I would think in an independent medical 
exam there wouldn ' t be any opinions given . You'd 
just be expected to show up. The doctor reviews your 
information ; looks at you ; does whatever test that 
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nee d s to be - - needs to have done ; and says " Thank 
you . Appreciate you showing up . If , if I ' ll 
report to the people that hired me to do the job ." 
And that ' s it . 
Q . Yeah . Okay . Was it your under st and i ng 
at t he t i me you went to see Dr . Zuckerman that you 




So what was your understanding of the 
p u r p ose of your visit to see Dr . Zu ckerman? 
A . J ust that t h e State had requeste d that I 
go t here for an evaluat i on . 
Q. Had you ever heard of an indepe n dent 
medical evaluation befor e this time? 
A . I don ' t bel i eve so . Probably -- the 
answer is probably yes , but not in those terms . 
Probably not the actua l description of it . 
Q . Wh at were yo u aware of with regards to 
this type of examination prior to your going to see 
Dr . Zu cke r man? 
A . I think I was comfortable with the idea 
or familiar with the idea that there wo u ld be -- that 
they were completely within their rights to ask for 
another person to look at you to make a n evaluation , 
to make a diagnosis if necessary . 
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Q . Thank you . Go ahead . 
A . I think , I think I didn ' t realize that 
that would be in Boise . I guess I thought it would 
probably be 
Q. 





more local , but . 
Did you have an understanding of who 
Zuckerman to perform this evaluation? 
Yes . 
And who was that? 
The State Insurance Fund . 
At the time this was done , you didn ' t 
think that you were going to have to pay for it? 
A . No . 
was 
Q . Or your health care provider , Bl ueShield , 
correct? 
I don ' t believe so , no . A. 
Q . Okay . How long were you there for this 
visit with Dr . Zuckerman? 
A . Just probably two hours , two and a half 
hours at the most . 






No , no . 
Did you ask him for one? 
No . 
Did you ask Dr . Zuckerman if he would 
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Did he offer to take over your treatment? 
No . 
What was that? 
No. I believe we did ask him what he 
thought -- what his recommendations for treatment 





your illness . 
A. 
And that would be natural to ask another 
Yes . 
that you would like to know more about 
Of , of his stature and I mean his 
position . I do have a lot of respect , have worked in 
the past with Misty as a hospice director and knew , 
knew of their reputation . 
Q. After you left Dr . Zuckerman ' s office 








Who did you consider to be your treating 
Still Dr . Dickson . 
And he is to this day? 
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No , no. He ' s --
Who is your treating physician now? 
Don ' t know his first name . Dr . Quan in 
Phoenix , the Cancer Treatmen t Center of America . 
Q . And I , I should probably say that ' s your 









No . Oncology . 
Yes , for oncology . 
Yes , that ' s correct . 
I ' m sorry . 
Okay . So you only saw Dr . Zuckerman 
That ' s correct . 
Have you ever seen him since? 
No . 
Q. Did you ever attempt to make a subsequent 








Did you ever ca ll h i m after that first 
No . 
Did you communicate with him in any way 




Did you ever ask him for further 
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At the time you were with him , did , did , 
did he ever consent to be your doctor while you were 
there with him? 
A . Unh-uh . (Negat ive.) Not that , not that 
I --
Q. Is that a no? 
A . Not that I remember , no . 
Q. And , by the way , you ' ll have to say yes 
or no. 
A . Oh . Unh -uh doesn ' t work? 
Q. She can ' t take down an uh - huh or a n 
unh - uh . 
A . Okay . 
Q. I was curious . You said in previous 
testimony that you may have signed something , but 
you ' re not sure. Can you sta te with some certainty 
that you signed something while you were there at 






Yes. I signed something . 
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several , signed several things . 
Q . But you don ' t remember what they were? 
A . No. 
Q. Did you ever tell Dr. Zuckerman that you 








Did it occur to you at the time? 
Yeah. 
But you didn ' t ask him? 
No, no. Geographically unworkable . 
I ' m curious if you considered your --
that you were placing yourself in his care at the 






In, in, in terms of treatment? 
Yes . 
No. 
I guess care and treatment seem to go 
I use the word " care "; but in his care and 
treatment , is that a better way to phrase it then? 




I don ' t think so . 
Okay . Was there any contract or 
agreement made between you and Dr. Zuckerman , either 
oral or written , at the time you were - - you met with 
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him for that , that visit? 
A. In terms of treatment you mean or --
Q. Any kind of contract , oral or written , 





Certainly not for medical services? 
Not to my know -- well , no . Not , not for 
continuing medical services , no . 
Q. Did you expect to receive future medical 




I believe you indicated that you were 
retired as of last November? 
A. Uh-huh . (Affirmative . ) 
Q. Is that a yes? 
A . Yes . I ' m sorry. 
Q. Are you working at all now? 
A . No . 
Q. After you saw Dr . Zuckerman , did you 




Do you specifically remember giving your 
health insurance information to Dr . Zuckerman ' s 
office? 
A . Not specifically . Just, just a vague 
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recollection that , that they - - that we did all the 







So you may have filled out some forms? 
Yes. 
But you don't recall what those forms 
No . History and Physical , but I'm not --
again , it ' s just recollection. 
that visit . 
It ' s not specific to 
Q. And in your experience , that ' s pretty 
common to fill out a patient history and physical 




Did you consider yourself to be 
Dr . Zuckerman ' s patient? 
A . No . 
MR . FULLER : That ' s all the questions I have . 
REFEREE DONOHUE: Okay . Redirect. 
REDIRECT EXAMINATION 
BY MR . ADAMS : 
Q. In , in response to - - scratch that . 
You said you did not feel like you were his 
patient? 
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Oh-huh . (Affirmative . ) Yes . 
Besides the recommendations earlier, on 
Page 2 i n the exhibits , it talks about him wanting to 
see your -- he said -- I ' ll just -- I can quote the 
line . Oh , I can , I can read it? Okay . 
So it says , " I will be having the patient see 
our drug coordinator person in hopes of obtaining " 
I ' m going to have you pronounce that one for us. 
It 's on Page 2 . It ' s on the History and Physical . 




But it says , " I will be having the 
patient see our drug coordinator person " 
A . 
Q. 
Oh-huh. (Affirmative . ) 
" in hopes of obtaining the Tarceva and 
Fragmin for him through the pharmaceutical companies , 
although apparently this has been attempted 




Could you tell me a little bit about what 
was going on there where he wanted to have you see 
the drug coordinator? 
A . If the EGFR was positive , that would have 
been the Tarceva recommendations ; and we had been 
insurance wouldn ' t pay for Tarceva . Good heavens . 
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Which one wouldn ' t they pay for? No . It was the 
heparin that they wouldn ' t pay for I think . 
The Fragmin , Fragmin is a single dose per day 
injection of heparin, and they wouldn ' t pay for that 
to be done outside of a medical facility . You 
couldn ' t get a prescription for it , self - administer 
it ; had to be done through a facility , through , 
through a medical facility . 
Q. And he wanted you to see his drug person 
coordinator -- or his drug coord i nator for that or 
any drug coordinator for that? 
A. Well, he talked abo u t his drug 
coordinator , ab out visiting with her ; and we did . 
She came in ; and we talked about what, what had been 
done and what they thought could be done . I don ' t 
have a recollection that she did anything 
specifically but other than review with us what we ' d 
done and what , what the possibilities were . I know 
we met with her ; but , but the conversation lS --
Q. Did she give you a drug at that day? 
A . No. 
Q . No? 
A . No . 
Q. Okay . In cross - examin ing, you talked a 
little bit about your wife , Denise. 
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Uh - huh. (Affirmative . ) 
Has she been there throughout this whole 
Yes . 
-- watching th is? 
Yes . 
Anybody else a round there , 
No , unh-uh . (Negative . ) 
family that ' s 
Not , not that 




Okay . So she , she ' d be your only 
Yes . 
Q . Okay . Just a co u ple more questions . If 
we were to -- that ' s probably speculative . So let me 
cross that out . 
But does BlueShield have a record of all of 
your -- does BlueShield have -- would they have a 
record of everywhere you ' ve been between your private 




Up till last , I think , December , yes . 
Okay . 
The city changed insurances right in 
there . I ' m not sure if it was October 1st o r 
December 1st. They changed fr o m , from BlueShield to 
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-- in that area someplace . 
Okay. And I think -- I guess my -- and 
I , I know that this question ' s been asked. We 'r e 
going to ask it in just a little bit of a different 
way . 
So when you went there to Dr . Zuckerman ' s 
office and you filled out those paperwork -- that 
paperwork , was there anything there that you filled 
out t hat was different than the o ther doctors you ' ve 




Not , not that I recall . 
So there wasn 't any paper you l ooked at 
and said, well , this , this is ou t of the ordinary? 
A. No, unh-uh. (Negative . ) 
Can ' t get rid of that unh - uh , uh - huh. 
MR . ADAMS : Okay . I think we ' re -- I , I think 
I have no more questions . 
REFEREE DONOHUE : Okay . You can have a seat 
then . 
MR . FULLER : I have one . 
REFEREE DONOHUE : Oh , you do? 
MR . FULLER: I do . 
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REFEREE DONOHUE : Go ahead then. Excuse me. 
THE WITNESS : Okay . 
RECROSS EXAMINATION 





There was some discussion about the drug 
Uh - huh. (Affirmative . ) 
-- that Dr . Zuckerman had referred you 




Yes , uh-huh. (Affirmative . ) 
And was he , was he referencing you to 
that drug coordinator to assist you with 
prescriptions made by Dr . Dickson? 
A . No . 
1 
I think he was trying to -- well , 
l et ' s see. Good question . I don ' t , I don ' t recall 
what -- where we were at in the treatment protocol at 
that time . We were --
Q. Well , certainly it wasn't for any drug 
that Dr. Zuckerman had prescribed because you already 
testif i ed he hadn't prescribed any drugs for you . 
A. Right. We had the discussion about the 
Tarceva , about getting the Tarceva if , if the EGFR 
was positive ; and I don ' t recall the text of , you 
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He was just trying to help you out --
Yes . 
-- if you needed that help had the 
Tarceva been recommended? 
A. The drug of choice , uh-huh . 
(Affirmative.) 
Q. Yes . And that would only occur after 





-- had taken place , correct? 
Yes . 
MR . FULLER: That 's all I have. 
REFEREE DONOHUE : Okay. You get the last shot 
if you want it . 
MR. ADAMS: Okay. Just one or two questions 
just on that same point. 




FURTHER REDIRECT EXAMINATION 
So the Tarceva? 
Uh-huh . (Affirmative .) 
And the Fragmin were going to be 
recommended after the EGFR was done? 
A. I don ' t remember -- it kind of seems in 
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my mind that we were - - had started Tarceva and that 
Dr. Zuckerman said , " Why? " He was questioning why 
we ' d done that because there was no documentation 
that I ' d brought to him that , if that ' s correct , that 
the EGFR had been done because I think in his mind , 
in his medical practice , the EGFR would have been 
done prior to prescribing Tarceva , prior to ever 
starting . 
Q . And he , as in Dr . Zuckerman wanted you 
to see his drug -- oh , wait . Scratch that . 
Was it your understanding on 12 - 8 of ' 09 that 
he want - - that Dr . Zuckerman wanted you let me 
ask this question a bit differently . Sorry about 
that . 
What was your understanding of the drug 
coordinator ' s duty that day? 
A . Just to help us evaluate what medications 
were out there . Whether or not we could get the 
Fragmin I think was the biggest one . I don ' t 
remember the conversation specifically about Tarceva ; 
but , but the Fragmin was a big one , that , that we 
weren ' t - - trying to think how the , how the -- the 
best way to explain it . 
To do it the way that we were normally done 
would hav e been -- we would have had to pay for it 
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out of pocket . Insurance wouldn't have covered it at 
all , and so they were trying to help us find ways 
either through foundations or , or way work around 
through the insurance company so that we could get 
that anticoagulant because it was the only thing 
available. The only other anticoagulant was twice a 
day , shot in the abdomen , any fatty tissue . But it 
just -- it ' s , it ' s a shot ; and it , it was nasty . 
MR . ADAMS : 
all my questions . 
I , I think that's -- I think that's 
THE WITNESS : Okay . 
REFEREE DONOHUE : All right . You ' re excused 
then . 
THE WITNESS : Thanks . 
REFEREE DONOHUE : 
take it? 
No other witnesses today I 
MR . ADAMS: No other witnesses today . 
REFEREE DONOHUE : Okay . And we have a 
post-hearing deposition I presume of Dr . Zuckerman . 
Is there any other? 
MR . FULLER : No . 
REFEREE DONOHUE : Okay . 
MR . FULLER : Just for the record , I ' d like to 
make sure that we understand that all other issues 
are reserved --
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REFEREE DONOHUE : Yes , of course . 
MR. FULLER : -- by the parties. All rights to 
complete or pursue further discovery or medi c al 
examinations by either party are also reserved . 
We ' re just focusing o n this one issue . I think 
that ' s correct . 
REFEREE DONOHUE: Absolutely bifurcated , and I 
think it ' s a very interesting issue . But I ' m not 
going to go beyond it when I look at it . 
MR. FULLER : Well , I just wanted to make sure 
that counsel is in agreement with that. 
MR . ADAMS : Yep . 
MR. FULLER: Okay . 
REFEREE DONOHUE: If at all possible , I would 
like to accelerate the briefing schedule because it ' s 
such a limited issue , and there ' s a limited amount of 
evidence on the thing . 
How soon after Dr. Zuckerman 's deposition do 
you think you can be ready with a brief? 
I ' ve 
know 
MR. ADAMS : I ' m kind of at a loss on that one. 
it'll be my first brief writing , and I don't 
MR . CURTIS : I 'l l help you . 
MR . ADAMS : Okay . So , Paul -- as soon as you 
want i t don e . 
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MR . CURTIS: We ' ll get it done within 30 days 
REFEREE DONOHOE : Thirty days . 
MR . CURTIS : - - or 21 days. 
MR . ADAMS : Yeah . 
REFEREE DONOHUE : Well , we ' ll give you 30 days 
till after the deposition . That will take care of 
transcription time if there ' s ever a problem with 
that . Roughly . I ' ll send out an order giving you 
the exact date , but roughly 30 . 
And then two weeks? Three weeks? 
MR. FULLER : Three . 
REFEREE DONOHUE : Three , okay . And then two 
weeks for the reply . 
Okay . We ' ll work off of that kind of a system . 
The idea is that if we can get the briefing done 
faster , then I can make my decision faster . And , 
frankly , I ' ll put this one to the head of the line . 
First of all , it ' s interesting ; and second of all , 
it ' s such a limited issue , that it ' s something that 
doesn ' t need to stand in line behind the other cases 
for me to decide . So we ' ll do it that way . 
Okay. We ' re in rec ess. 
MR . FULLER : We haven ' t , we haven ' t yet firmed 
up a date for Dr . Zuckerman . 
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REFEREE DONOHUE : Okay . 
MR . FULLER : But we will as soon as I can make 
my way through the St. Luke ' s . 
REFEREE DONOHUE : Okay . I will hold off 
putting the order in or issuing the order on briefing 
until I receive the notice o f depos i tion with the 
specific date for Zuckerman ; and if something comes 
up between now and then , just give me a shout. I ' m 
easy on br i ef i ng schedule dates , but I just would 
l i ke to accelerate this if possible . 
MR. FUL L ER : I think t hat would be appropriate . 
REFEREE DONOHUE : Al l right . 
(Proceedings recessed at 2 : 36 p . m . ) 
-000 -
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writing 111 - 52 :21 
39:4 28 :1, 35:24 , 36 :2, written [SJ - 3:21, 30:9, 
treatment l31J - 2:25, 46 :21 , 53 :25, 54 :8 
30 :16, 41 :25, 42:3 
8:2, 9 :13, 9:18, 10:1, upset 111- 20:3 
wrote 111 - 29:16 urban 111 - 7:13 10:2, 10:9, 10:10, 
10:13, 12:5, 13:1 , 13:3, Utah 111 - 9:17 
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